Dr. Kendra Lynn Sweet, MD

  • Tampa, FL
  • Hematologist and oncologist
NPI1609074574PAC ID8426238973
Medicare services, 2024
44
Medicare patients, 2024
28
Part D claims, 2024
89
Publications
93
Clinical trials
9
Practice address
12902 Magnolia Dr, Tampa, FL 33612
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Moffitt Cancer Hospital

Hospital · Tampa, Florida

See all 3 affiliations

Find Dr. Sweet's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kendra Lynn Sweet is a hematologist and oncologist in Tampa, Florida

Dr. Sweet practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Sweet's NPI, 1609074574, was assigned on July 3, 2007. Dr. Sweet graduated from VCU School of Medicine in 2007. Dr. Sweet holds Florida license ME106128.

NPI and contact details
Medicare PAC ID
8426238973
NPI enumeration date
July 3, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
45
Medical school graduation
2007

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kendra Lynn Sweet practices at Moffitt Cancer Hospital in Tampa, Florida

Dr. Sweet's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Source: Dmand AI Affiliation Data

Dr. Kendra Lynn Sweet is affiliated with 2 sites of care and 1 medical group

Dr. Sweet's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Sweet to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Sweet

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Kendra Lynn Sweet's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sweet practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Moffitt Cancer HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Sweet practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Moffitt Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kendra Lynn Sweet is one of 693 hematologists and oncologists in Florida

Hematology and oncology is Dr. Sweet's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sweet is board certified in hematology by the American Board of Internal Medicine. Dr. Sweet is licensed in Florida.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME106128 · 2010 to 2026 · taxonomy 207RH0003X

Clinical focus

Dmand AI lists chronic anemia, chronic leukemia, lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Sweet treats.

Hematologists and oncologists near Dr. Sweet

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kendra Lynn Sweet billed Medicare for 44 services in 2024

CMS data shows 44 Medicare services from Dr. Sweet across 1 procedure code in 2024, all of them office visits, for 28 Medicare patients. Medicare paid $2,803 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 202444
Medicare patients28
Paid by Medicare$2,803
Procedure codes1

Dr. Sweet's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1372024: 4468%

Dr. Sweet compared with the Florida median for hematologists and oncologists, 2024

  • Dr. Sweet
  • Florida median
Medicare services
44vs 69794% below
Medicare patients
28vs 21887% below
Part D claims
61vs 34182% below

Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Sweet's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Sweet

Need commercial claims for Dr. Sweet?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sweet and other hematologists and oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Kendra Lynn Sweet treated 28 Medicare patients in 2024, average age 70

CMS counts 28 Medicare patients who saw Dr. Sweet in 2024. The largest group is 75 to 84, with 12 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sweet's median patient age at 69, with 44% women.

Medicare patients, 202428
Average age70
Average risk score2.07

Dr. Sweet's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Sweet's Medicare patients by sex, 2024

  • Women1346%
  • Men1554%

Chronic conditions among Dr. Sweet's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure71%
  3. Arthritis57%
  4. Chronic kidney disease50%
  5. Anxiety39%

Share of Medicare patients with each condition. A patient can have several.

Dr. Sweet's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women44%
  • Men55%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Kendra Lynn Sweet wrote 89 Medicare Part D claims in 2024

In 2024, Dr. Sweet wrote 89 Medicare Part D claims for 17 patients. 36% of them were for generic drugs. CMS names the drug for 61 of them, across 4 drugs with 11 or more claims each, at $442,395 in total drug cost. In 2023, CMS named 114 claims across 6 drugs.

Part D claims, 202489
Drugs named by CMS4
Total drug cost$442,395
Part D patients17

Dr. Sweet's Part D claims by kind of drug, 2024

  • Generic32 claims36%
  • Brand-name57 claims64%

Dr. Sweet's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1142024: 6146%

Drugs named by CMS: 4 in 2024, 6 in 2023.

See all prescribing by Dr. Sweet

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Kendra Lynn Sweet scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sweet for performance year 2024, reported as part of a group. Dr. Sweet accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Sweet's MIPS scores, performance year 2024

  • 88of 100Final score
  • 74of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Sweet by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kendra Lynn Sweet has 93 publications on record

Dmand AI links 93 papers to Dr. Sweet, published from 2012 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Leukemia, Myeloid, Acute, Myelodysplastic Syndromes and Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Dr. Sweet has published most often in Clin Lymphoma Myeloma Leuk. Dr. Sweet's most frequent co-authors are Jeffrey E. Lancet, MD, Rami Salah-Eddin Komrokji, MD and David A. Sallman, MD.

Papers93
Years published2012 to 2025

Dr. Sweet's papers by year, 2016 to 2025

Topics Dr. Sweet writes about most

  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Protein Kinase Inhibitors
  • Antineoplastic Combined Chemotherapy Protocols
  • Hematopoietic Stem Cell Transplantation
  • Remission Induction
  • Pyrimidines

Dr. Sweet's most frequent co-authors

Recent publications by Dr. Sweet

See all 93 publications and co-authors

See who Dr. Sweet researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sweet works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Kendra Lynn Sweet has worked on 9 clinical trials

Dmand AI links Dr. Sweet to 9 clinical trials, 3 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic-Phase and Myelodysplastic Syndromes. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 4.

Clinical trials with Dr. Sweet by phase

  1. 1Phase 1: 1 trial
  2. 2Phase 1/2: 2 trials
  3. 3Phase 2: 3 trials
  4. 2Phase 3: 2 trials
  5. NonePhase 4: no trials

Conditions in Dr. Sweet's trials

  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid, Chronic-Phase
  • Myelodysplastic Syndromes
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Leukemia, Myeloid

Investigators on the most trials with Dr. Sweet

Recent clinical trials with Dr. Sweet

See all 9 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Kendra Lynn Sweet received $231,905 in industry payments from 2016 to 2025

CMS Open Payments shows 200 general payments to Dr. Sweet from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Novartis Pharmaceuticals Corporation paid the most, $62,406. It also lists 6 research payments totaling $18,518 from 2017 to 2024.

General payments to Dr. Sweet by program year, 2016 to 2025

General payments to Dr. Sweet by kind, 2016 to 2025

$231.9Kin total
  • Consulting fees$140,27662%
  • Speaker and faculty fees$33,26715%
  • Education$24,02811%
  • Travel and lodging$16,1637%
  • Other$12,0465%

Companies that paid Dr. Sweet the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Sweet

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Kendra Lynn Sweet graduated from VCU School of Medicine

Dr. Sweet graduated from VCU School of Medicine in 2007.

  1. Medical schoolVCU School of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Kendra Lynn Sweet accepts plans from 9 insurance carriers

Dr. Sweet is in network with 9 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.

  • Excellus BlueCross BlueShield
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Humana
  • Molina
  • Aetna
  • Alliant Health Plans
  • Blue Cross and Blue Shield of Kansas City
  • +1 more carriersWith a free account

Plan types Dr. Sweet accepts, by number of carriers

  1. HMO6
  2. Medicare5
  3. POS4
  4. PPO4
  5. EPO2

Source: Dmand AI Insurance Network Data

Sources for Dr. Kendra Lynn Sweet's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kendra Lynn Sweet

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kendra Lynn Sweet's NPI number?

Dr. Kendra Lynn Sweet's NPI number is 1609074574. It was assigned on July 3, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Kendra Lynn Sweet?

Dr. Kendra Lynn Sweet is a hematologist and oncologist in Tampa, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Kendra Lynn Sweet practice?

Dr. Sweet practices at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Sweet's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dmand AI also links Dr. Sweet to 1 group practice or clinic.

What is Dr. Kendra Lynn Sweet's medical license number?

Dr. Sweet holds Florida license ME106128.

Which hospitals is Dr. Kendra Lynn Sweet affiliated with?

Dr. Sweet practices at Moffitt Cancer Hospital in Tampa, Florida.

What medical group is Dr. Kendra Lynn Sweet part of?

Dr. Sweet is linked to Moffitt Cancer Center.

Does Dr. Kendra Lynn Sweet accept Medicare?

Yes. CMS data shows Dr. Sweet billed Medicare for 44 services in 2024, and Dr. Sweet accepts Medicare assignment.

What is Dr. Kendra Lynn Sweet's MIPS score?

Dr. Sweet's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

How many Medicare patients does Dr. Kendra Lynn Sweet see?

CMS counts 28 Medicare patients who saw Dr. Sweet in 2024, with an average age of 70.

Is Dr. Kendra Lynn Sweet board certified?

Yes. Dr. Sweet is board certified in hematology by the American Board of Internal Medicine.

Show 8 more questionsShow fewer questions

What services does Dr. Kendra Lynn Sweet bill to Medicare?

In 2024, Dr. Sweet's most billed Medicare services were office visit, established patient (99214).

Where did Dr. Kendra Lynn Sweet go to medical school?

Dr. Sweet graduated from VCU School of Medicine in 2007.

What drugs does Dr. Kendra Lynn Sweet prescribe most?

In 2024 Medicare Part D data, Dr. Sweet's most prescribed drugs by claims were Bosulif, Imatinib Mesylate and Ondansetron HCl.

Has Dr. Kendra Lynn Sweet received payments from drug or device companies?

CMS Open Payments shows $231,905 in general payments to Dr. Sweet from 20 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Kendra Lynn Sweet been practicing?

Dr. Sweet graduated from medical school in 2007, 19 years ago.

Does Dr. Kendra Lynn Sweet do research?

Dmand AI links 93 publications to Dr. Sweet, published from 2012 to 2025. Dr. Sweet has worked on 9 clinical trials.

Who does Dr. Kendra Lynn Sweet publish with?

Dr. Sweet's most frequent co-authors are Jeffrey E. Lancet, MD (52 shared papers), Rami Salah-Eddin Komrokji, MD (49 shared papers) and David A. Sallman, MD (44 shared papers).

What insurance does Dr. Kendra Lynn Sweet accept?

Dr. Sweet is in network with 9 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)